Anandamoy Rudra, R Manasa Deepa, Miltu Kumar Ghosh, Subhajit Ghosh, Biswajit MukherjeeDepartment of Pharmaceutical Technology, Jadavpur University, Kolkata (Calcutta), IndiaIntroduction: Phosphatidylethanolamine (PE)-conjugated nanoliposomes were ...
R Manasa Deepa +3 more
core
Clinical Outcome in Elderly Patients (Aged ≥ 65 Years) Treated with Chemotherapy for Advanced Soft Tissue Sarcomas: A Tokai Musculoskeletal Oncology Consortium Study. [PDF]
Nakamura T +13 more
europepmc +1 more source
Dietary trans fats enhance doxorubicin-induced cardiotoxicity in mice
[[abstract]]This study investigated the combined effects of trans fat diet (TFD) and doxorubicin upon cardiac oxidative, inflammatory, and coagulatory stress. TFD increased trans fatty acid deposit in heart (P 0.05).
蒙美津;Mong, Mei-Shin;Hsia, Te-Chun;Hsia, Te-Chun;殷梅津;YIN, MEI-CHIN
core
Antitumor Activity of Liposomal Nanoparticles Co-Encapsulating Ceramides and Doxorubicin in In Vitro Nucleolin-Expressing Neuroblastoma Models. [PDF]
Bensa V +9 more
europepmc +1 more source
Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery
Sang Joon Lee,1,* Young-Il Jeong,2,* Hyung-Kyu Park,3 Dae Hwan Kang,2,4 Jong-Suk Oh,3 Sam-Gyu Lee,5 Hyun Chul Lee31Department of Biomedical Sciences, Chonnam National University Medical School, Gwangju, 2Biomedical Research Institute, Pusan National ...
Jeong YI +6 more
core
ABSTRACT The global trend toward sustainable and intensified bioprocesses is driving innovation in the design and scalable synthesis of liposomal nanocarriers, a cornerstone of modern drug delivery. For decades, these nanosystems have relied exclusively on polyethylene glycol (PEG) for their sustained circulation in vivo, but they are currently ...
Chandra Has
wiley +1 more source
Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity. [PDF]
Wang Q +27 more
europepmc +1 more source
Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma [PDF]
Bogner, Johannes R. +6 more
core
While the event‐free survival (EFS) of children treated for acute lymphoblastic leukaemia (ALL) has improved greatly in the last decades, the EFS for patients diagnosed with ALL before the age of one is still under 50%. This outcome further decreases when infants have a rearrangement in the gene encoding histone‐lysine N‐methyltransferase 2A (KMT2A ...
Tirsa de Kluis +5 more
wiley +1 more source
Characteristics and Outcomes of Patients With Dedifferentiated Liposarcoma in a US Community Setting. [PDF]
Butrynski JE +10 more
europepmc +1 more source

